Halichondrin B amide acts as tubulin binding agent to exhibit anti-tumor efficacy in hematologic cancers

Por Li, Ying-Chun, Zhang, Rong, Yang, Ying, Li, Jia, Zhu, Ke, Yao, Kun, Liu, Zhuo-Gang
Publicado no Int J Clin Exp Med (2015)

Reversion of Multidrug-Resistance by Proteasome Inhibitor Bortezomib in K562/DNR Cell Line

Por Wang, Hui-han, Li, Ying-chun, Liao, Ai-jun, Fu, Bei-bei, Yang, Wei, Liu, Zhuo-gang, Wang, Xiao-bin
Publicado em 2011

Improved Response Rates with Bortezomib in Relapsed or Refractory Multiple Myeloma: An Observational Study in Chinese Patients

Por Lin, MaoFang, Hou, Jian, Chen, WenMing, Huang, XiaoJun, Liu, ZhuoGang, Zhou, YuHong, Li, Yan, Zhao, Taiyun, Wang, LinNa, Wu, Kwang-Wei, Shen, ZhiXiang
Publicado em 2014